Pembrolizumab-induced cyclic ACTH-dependent Cushing's syndrome treated by a block-and-replace approach with osilodrostat
- PMID: 34871599
- DOI: 10.1016/j.ando.2021.11.007
Pembrolizumab-induced cyclic ACTH-dependent Cushing's syndrome treated by a block-and-replace approach with osilodrostat
Keywords: Cushing's syndrome; Immunotherapy; Immunothérapie; Osilodrostat; Pembrolizumab; Penbrolizumab; Syndrome de Cushing.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources